BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 12143190)

  • 1. Histopathological features and clinical course of the gastrointestinal stromal tumors.
    Di Matteo G; Pescarmona E; Peparini N; Di Matteo FM; Zeri KP; Mascagni D; Mele R; Maturo A; Redler A; De Antoni E
    Hepatogastroenterology; 2002; 49(46):1013-6. PubMed ID: 12143190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumors: are they of cajal cell origin?
    Wang X; Mori I; Tang W; Utsunomiya H; Nakamura M; Nakamura Y; Zhou G; Kakudo K
    Exp Mol Pathol; 2002 Apr; 72(2):172-7. PubMed ID: 11890726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological analysis of gastrointestinal stromal tumors.
    Noguchi T; Sato T; Takeno S; Uchida Y; Kashima K; Yokoyama S; Müller W
    Oncol Rep; 2002; 9(6):1277-82. PubMed ID: 12375034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome.
    Reith JD; Goldblum JR; Lyles RH; Weiss SW
    Mod Pathol; 2000 May; 13(5):577-85. PubMed ID: 10824931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal mesenchymal tumors - immunophenotypic classification and survival analysis.
    Rudolph P; Chiaravalli AM; Pauser U; Oschlies I; Hillemanns M; Gobbo M; Marichal M; Eusebi V; Höfler H; Capella C; Klöppel G
    Virchows Arch; 2002 Sep; 441(3):238-48. PubMed ID: 12242520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors--a clinicopathologic and immunohistochemical study of eighty-eight cases.
    Miettinen M; Sarlomo-Rikala M; Sobin LH
    Mod Pathol; 2001 Oct; 14(10):950-6. PubMed ID: 11598163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastrointestinal stromal tumors: current issues].
    Lattarulo S; Ugenti I; Ferrarese F; Fabiano G
    Chir Ital; 2003; 55(2):219-26. PubMed ID: 12744097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
    Miettinen M; Lasota J
    Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
    Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry and c-kit gene analysis in determining malignancy in gastrointestinal stromal tumors.
    Yamaguchi M; Tate G; Endo Y; Miyaki M
    Hepatogastroenterology; 2003; 50(53):1431-5. PubMed ID: 14571755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical and ultrastructural heterogeneity of gastrointestinal stromal tumors].
    Handra-Luca A; Nahon P; Fléjou JF; Molas G; Dubois S; Sauvanet A; Belghiti J; Ruszniewski P; Degott C; Terris B
    Gastroenterol Clin Biol; 2001; 25(6-7):664-8. PubMed ID: 11673733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic assessment of gastrointestinal stromal tumor.
    Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
    Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors.
    Motegi A; Sakurai S; Nakayama H; Sano T; Oyama T; Nakajima T
    Pathol Int; 2005 Mar; 55(3):106-12. PubMed ID: 15743318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of gastrointestinal stromal tumors.
    Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
    Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.